Grassilli et al. (29) reported that GSK3B induced resistance to the necrotizing effect of certain antitumor drugs in p53-deficient colorectal cancer (CRC) cells whereas GSK3B knockdown had the opposite effect. This evidence concerns the gene TP53 and colorectal cancer.